Why the study?
These guidelines were developed to provide evidence-based measures for the secondary prevention of myocardial infarction with due attention to evidence obtained in Japan.
Answers are grounded in this paper and cite their sources.
The 2011 JCS guidelines provide updated recommendations for secondary prevention of MI tailored to the Japanese clinical context.
JCS Joint Working GroupRecommendations are classified as follows.Drugs or other treatments are: clearly effective for secondary prevention (Class I); can be effective, but not yet established (Class IIa, IIb); or not effective or potentially harmful (Class III). Classification of RecommendationsClass I: Conditions for which there is evidence and/or general agreement that a given procedure/therapy is useful/effective.Class II: Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure/therapy.Class IIa: Weight of evidence/opinion is in favor of usefulness/efficacy.Class IIb: Usefulness/efficacy is less well established by evidence/opinion.Class III: Conditions for which there is evidence and/or general agreement that a procedure/therapy is not useful/effective and in some cases may be harmful.Levels of evidence show that data are derived from multiple large-scale randomized clinical trials (Level of Evidence: A), or observational and other nonrandomized studies (Level of Evidence: B), or there is only expert consensus opinion (Level of Evidence: C). Levels of EvidenceLevel of Evidence A: Data are derived from multiple largescale randomized clinical trials.Level of Evidence B: Data are derived from randomized clinical trials that involved small numbers of patients or from careful analyses of nonrandomized studies or observational studies.Level of Evidence C: Expert consensus opinion is the primary basis for the recommendation. Specific Measures for Secondary Prevention of Myocardial InfarctionThe present guidelines provide the following measures for secondary prevention of MI, based on the aforementioned classifications and paying due attention to evidences obtained in Japan.234 JCS Joint Working Group 2. Adaptive servo ventilator is useful for MI patients with heart failure, regardless of whether or not they have sleep apnea syndrome.(Level of Evidence: B) 5. Management of Alcohol Use 49-52 Class I Heavy drinking should be avoided.(Level of Evidence: B) 6. Measures Against Depression, Anxiety Disorder, and Insomnia 53-58 Class I Post-MI patients should be counseled about depression, anxi-ety disorder, and insomnia, and assessed for possible effects of their social and family environments.(Level of Evidence: B) 7. Patient Education 59-64 Class I 1. Patients with MI should be fully educated before discharge regarding how to prevent recurrent MI including lifestyle modifications and how to take prescribed drugs appropriately.(Level of Evidence: B) 2. Patients and their families should be educated to understand acute symptoms of MI, angina, and other cardiovascular diseases and how to deal properly with such symptoms.(Level of Evidence: C) II Pharmacotherapy 1. Antiplatelet Agents and Anticoagulants 65-75 * 1 See Table 1.32 * 2 Low-risk patients are defined as those in whom reperfusion therapy has been successful, and left ventricular function is normal or nearnormal, and who do not have serious ventricular arrhythmia.ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; BMI, body mass index (weight [kg] ÷ height [m] ÷ height [m]); CPAP, continuous positive airway pressure; CRT, cardiac resynchronization therapy; CRT-D, cardiac resynchronization therapy device that incorporates both pacing and defibrillation capabilities; CRT-P, cardiac resynchronization therapy-pacemaker; EPA, ethyl icosapentate; HbA1c, hemoglobin A1c; ICD, implantable cardioverter defibrillator; JDS, Japan Diabetes Society; LDL, low density lipoprotein; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NYHA, New York Heart Association; PDE, phosphodiesterase; PVC, premature ventricular contraction; QOL, quality of life; RM, repetition maximum (10 RM means the intensity that allows 10 repeated movements).
No takes yet. Share an insight, caveat, or question.
JCS Joint Working Group (2012) studied Old myocardial infarction (secondary prevention). General treatment, pharmacotherapy, and invasive procedures for secondary prevention of myocardial infarction was evaluated on Cardiovascular accidents (cardiac death, nonfatal MI, drug-resistant angina, hospitalization due to heart failure, stroke, all-cause death, and coronary revascularization).
Synapse has enriched 10 related papers. Consider them for comparative context: